Hints and tips:
Showing results for ZHEJIANG HUAHAI PHARMACEUTICALS, CO., LTD.
Related Special Reports
...The two groups have invested $1bn in the project and are working to raise another $400mn for Jidu as losses balloon in the run-up to full production at Geely’s Zhejiang car plant, according to documents...
...Gilead has worked with scientists at Accelerated Clinical Trials Ltd to develop a blood cancer treatment....
Millions of Paxlovid pills have gone unused as tight controls restrict access
...They include Zhejiang Huayou Cobalt, China’s biggest producer of the key battery material, and Shanghai-listed Ronbay Technology, which dominates the global market for high-nickel cathode electrodes, as...
...Instead, Isomorphic chose to sign deals with just two pharmaceutical companies....
...But until recently, many large pharmaceutical companies were reluctant to invest heavily in finding treatments after decades of failure....
...Shares in Zhejiang Huahai rose 7.7 per cent in Shanghai on Tuesday....
...The virtue of putting private collections on public display is inculcated in Switzerland’s merchant class, the heirs to textile and pharmaceutical fortunes....
Shionogi chief warns companies are deserting the field to focus on more lucrative areas
...Thomas said she expected AlphaMissense to be used in healthcare as “a co-pilot for clinical scientists, flagging which variants they should be focusing on so that they can do their jobs more efficiently”...
Japan’s Eisai says it will not finalise Leqembi spending plans until government clarifies financial support
...It comes after decades during which many big pharmaceutical companies lost hope and cut investment in Alzheimer’s research....
...The US Food and Drug Administration in January approved lecanemab, a drug co-developed by Japanese drugmaker Eisai and US biotech Biogen, under an accelerated process....
...South Korea’s LG Energy Solution, the world’s leading non-Chinese producer of EV batteries, announced a partnership in April last year with Posco, two Indonesian state-owned companies and Chinese miner Zhejiang...
...One poster quotes an email they say was signed “Maximus Brainsby, Co-Founder, Pexgle.”...
...more than 10 per cent over the past five trading days while Shanghai Fosun Pharmaceutical added 7 per cent....
...“The days of easy money are gone,” said Luo Min, a premium baijiu distributor based in eastern Zhejiang province. “We need to be ready for normal growth in the years to come.”...
...Risk management Winner: Johnson & JohnsonOriginality: 8; Leadership: 9; Impact: 9; Total: 26The litigation team in Asia-Pacific designed a digital system for the pharmaceutical business to improve its management...
...Blackmores was established 91 years ago by Maurice Blackmore who co-founded one of the country’s first health stores in Brisbane in 1938....
...This year the only listing in Switzerland has been Chinese — Zhejiang HangKe Technology Incorporated Co, which manufactures lithium battery equipment and raised $172mn....
...That’d be bad news for Hikma Pharmaceuticals (27.2 per cent). What about board chairs and their deputies?...
...That is a step up from current drugs that treat only symptoms: a landmark success in a desert strewn with pharmaceutical failures....
...Deutsche Bank has hired Perella Weinberg Partners’ Marie-Soazic Geffroy as global co-head of its financial institutions group, based in Paris....
...Lecanemab, which was co-developed by Tokyo-based Eisai and US biotech Biogen, is a monoclonal antibody that acts by reducing the build-up of sticky plaques in the brain called beta-amyloid....
Daiichi Sankyo and AstraZeneca’s Enhertu could double time patients can live without their condition progressing
International Edition